Event Abstract

Hydroxyapatite-polycaprolactone membrane in the treatment of induced periodontal disease in dogs

  • 1 Universidade Federal de Viçosa, Veterinarya, Brazil

Conventional treatment for periodontal disease (PD) does not promote proper regeneration of the periodontium [1]. Therefore, the use of biomaterials in guided tissue regeneration technique has become a major focus of study. The present work utilizes a membrane composed of 60% hydroxyapatite (HAp) and 40% polycaprolactone (PCL). This formulation allows the combination of HAp bioactivity [2] with PCL mechanical properties [3], obtaining a flexible membrane with tissue integration potential. The project was previously approved by the Ethics Committee on Animal Use, #14/2012. Twelve dogs were subjected to induction of PD by production of chronic class II furcation defect on the third and the fourth premolars [4]. The animals were distributed into two groups: 1) control, which received conventional prophylaxis with daily teeth brushing and application of chlorhexidine solution twice a day for two weeks; and 2) treated, which, in addition to the periodontal prophylaxis, received the membrane between gingival flap and alveolar bone, to which it was fixed with a titanium screw. After 60 days, animals were euthanized and dental samples were harvested and fixed in formalin. They were analyzed by micro-computed tomography (MicroCT) for bone volume per total volume (BV/TV) and trabecular number, thickness and separation. Samples were processed for histology and histomorphometry, evaluating tissue inside the defect, inflammatory infiltrate and periodontal tissue regeneration. MicroCT showed a significant difference (p=0.042) for only BV/TV between control (36±0.08) and treated (0.20±0,15) groups, although no furcation defect was completely filled by bone. The standard deviation of treated group (0.748) was 3.5 times higher than control (0.213), what may have influenced the results. In both groups, defect was filled by organized connective tissue with diffuse spots of inflammatory infiltration. Bone formation was restricted to the apical edge of the defect, in which provisional matrix, active osteoblasts and newly formed bone matrix could be observed.

Moreover, the formation of a homogeneous laminar matrix along the tooth root was seen in some areas, where cementum is normally found but it was scraped off during the induction protocol.

Cementum regeneration occurs by proliferation of its cellular portion located in the apical third of the root. Therefore, cementoblasts produce a matrix that is replaced by Sharpey fibers, regenerating periodontal ligament [5]. However, natural occurrence of periodontal regeneration is limited [6] and, in this study, the membrane cannot be implied in favoring these events, because the laminar matrix formation was similar in both groups. The main difference related to treatment was the greater proliferation of connective and gingival epithelial tissues in control group. In treated group, the membrane may have limited tissue proliferation, but did not prevent the epithelial invasion, which is not desirable in guided tissue regeneration [7]. Also, the observed inflammatory infiltrate indicated the contamination of the membrane, probably due to a difficult adaptation to the defect area, also important for guided tissue regeneration [1]. Therefore, the HAp-PCL membrane reduced epithelial proliferation into the periodontal defect, however, did not promote a better regeneration of periodontal tissue than untreated group in the present study. 

 

CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil; FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais; CNPq - National Counsel of Technological and Scientific Development - Brazil

References:
[1] E.C.C. REIS, A.P.B. BORGES, M.V.F. ARAUJO et al., Periodontal regeneration using a bilayered PLGA/calcium phosphate construct, Biomaterials. Vol. 32, 2011.
[2] A.P.B. BORGES, C.F.M. REZENDE, M.F.B. RIBEIRO et al., Hidroxiapatita sintética como substituto ósseo em defeito experimental provocado no terço proximal da tíbia em cão: aspectos à microscopia eletrônica de transmissão, Arquivo Brasileiro de Medicina Veterinária e Zootecnia. Vol. 52, 2000.
[3] W.J. CHO, J.H. KIM, S.H. OH et al., Hydrophilized polycaprolactone nanofiber mesh-embedded poly(glycolic-co-llactic) membrane for effective guided bone regeneration, Journal of Biomedic Material Research. Vol. 91, 2009.
[4] R. V. SEPÚLVEDA, E. C. C. REIS, F. L. VALENTE et al., Evaluation of a model for induction of periodontal disease in dogs, Pesquisa Veterinária Brasileira. Vol. 34, 2014.
[5] M.G. ARAÚJO and J. LINDHE, GTR treatment of degree III furcation defects following application of enamel matrix proteins. An experimental study in dogs, Journal of Clinical Periodontology. Vol. 25, 1998.
[6] U.M.E. WIKESJÖ, W.H. LIM, R.C. THOMSON et al., Periodontal repair in dogs: evaluation of a bioabsorbable space-providing macro-porous membrane with recombinant human bone morphogenetic protein-2, Journal of Periodontology. Vol. 74, 2003.
[7] D.D. BOSSHARDT and A. SCULEAN. Does periodontal tissue regeneration really work?, Periodontology 2000. Vol. 51, 2009.

Keywords: in vivo, composite, Tissue Regeneration, biomedical application

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Biomaterials in dental applications

Citation: Martins LA, Valente FL, Sepulveda RV, Eleotério RB, Fernandez FT, Carlo Reis E and Borges AP (2016). Hydroxyapatite-polycaprolactone membrane in the treatment of induced periodontal disease in dogs. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02373

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.